PHILADELPHIA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit against Fiserv, Inc. (NASDAQ: FISV) (NYSE: FI) (“Fiserv” or the “Company”) has been filed on behalf of investors who purchased Fiserv shares during the period of July 23, 2025 through October 29, 2025 (the “Class Period”). Investor Deadline: Investors who purchased Fiserv securities during the Class Period may, no later than January 5, 2026, seek to be appointed as a lead pl ...

Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc for allegedly overstating demand in its North American Fiber Cement segment and downplaying distributor destocking during the Class Period from May 20, 2025, to August 18, 2025 [1][3]. Group 1: Lawsuit Details - The lawsuit claims that James Hardie misrepresented the demand for its products, leading to a significant drop in stock price after a reported 12% decline in segment sales on August 19, 2025, which resulted in a more than 34% decrease in stock value [3]. - Investors who purchased James Hardie securities during the Class Period have until December 23, 2025, to seek appointment as lead plaintiff representatives [2]. Group 2: Company Overview - James Hardie is a global building materials company that specializes in fiber cement products and is headquartered in Dublin, Ireland [2].

Core Viewpoint - A class action lawsuit has been filed against StubHub Holdings, Inc. for failing to disclose significant changes affecting its cash flow during its IPO period [1][3]. Group 1: Lawsuit Details - The lawsuit represents investors who acquired StubHub securities from September 14, 2025, to November 24, 2025, including shares from the September 2025 IPO [1][2]. - Investors have until January 23, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Company Background - StubHub is a major platform for reselling tickets for various live events, including sports, concerts, and theater performances [2]. - The company is headquartered in New York City [2]. Group 3: Legal Firm Information - Berger Montague PC is a leading law firm specializing in complex civil litigation and class actions, with a history of significant recoveries for clients [4]. - The firm has achieved over $2.4 billion in post-trial judgments in 2025 alone and has recovered over $50 billion for clients over its 55-year history [4].

PHILADELPHIA, Dec. 17, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) ("Integer" or the "Company") on behalf of investors who purchased or otherwise acquired Integer securities during the period of July 25, 2024 through October 22, 2025 (the "Class Period"), inclusive. Investor Deadline: Investors who purchased Integer securities during the Class Period may, no later than February 9 ...

PHILADELPHIA, Dec. 16, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) ("Stride" or the "Company") on behalf of investors who purchased Stride securities during the period of October 22, 2024 through October 28, 2025 (the "Class Period"). Investor Deadline: Investors who purchased Stride securities during the Class Period may, no later than January 12, 2026, seek to be appointed as a lead plaintiff r ...

PHILADELPHIA, Dec. 16, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit against Six Flags Entertainment Corp. (NYSE: FUN) ("Six Flags" or the "Company") has been filed on behalf of investors who purchased or acquired Six Flags shares July 1, 2024 through November 5, 2025 (the "Class Period"), including in connection with the merger between Six Flags and Cedar Fair L.P. (the "Merger"). Investor Deadline: Investors who purchased Six Flags securities ...

Core Viewpoint - A class action lawsuit has been filed against Telix Pharmaceuticals Ltd. on behalf of investors who purchased securities during the specified class period, alleging misleading statements regarding the company's business and operations [1][3]. Company Overview - Telix Pharmaceuticals Ltd. is a biopharmaceutical company based in Melbourne, Australia, focusing on the development of radiopharmaceuticals for cancer treatment [2]. Allegations - The lawsuit claims that the defendants made false or misleading statements, including: - Materially overstated progress on prostate cancer therapeutic candidates [3]. - Exaggerated quality and performance of the company's supply chain and partners [3]. - Resulting statements about the company's business, operations, and prospects were allegedly false or lacked a reasonable basis [3]. Investor Information - Investors who purchased Telix securities during the class period have until January 9, 2026, to seek appointment as lead plaintiff representative [2].

Core Points - A class action lawsuit has been filed against James Hardie Industries plc on behalf of investors who purchased its common stock and American Depositary Shares between May 20, 2025, and August 18, 2025 [1][2] - The lawsuit alleges that James Hardie made false and misleading statements regarding product demand and inventory levels during the Class Period [3] - Following a disclosure of a 12% decline in segment sales on August 19, 2025, the company's stock price fell over 34% in a single trading day [3] Company Overview - James Hardie Industries plc is a multinational building materials company based in Dublin, Ireland, specializing in fiber cement and related construction products [2] Legal Context - Investors who purchased James Hardie securities during the Class Period have until December 23, 2025, to seek appointment as lead plaintiff representative of the class [2]

Core Viewpoint - An investigation is underway regarding potential breaches of fiduciary duties by the Board of Directors of Warner Bros. Discovery, Inc. in relation to the proposed sale of the Company or its parts [1][3]. Group 1: Investigation Details - The investigation is being conducted by Berger Montague PC, focusing on whether the Board failed to maximize shareholder value during the sales process [3]. - The inquiry will assess if the Board adequately evaluated acquisition proposals for the Company or its divisions [3]. Group 2: Company Overview - Warner Bros. Discovery, Inc. is a multinational mass-media and entertainment conglomerate, involved in film and TV studios, streaming services, and cable/linear networks [2]. - The Company is headquartered in New York City [2]. Group 3: Law Firm Background - Berger Montague is a prominent law firm specializing in complex civil litigation, class actions, and mass torts, with over $2.4 billion in post-trial judgments in 2025 [4]. - The firm has recovered over $50 billion for its clients over its 55-year history [4].

MoonLake, based in Zug, Switzerland, is a clinical-stage biotech firm focused on advancing next-generation immunotherapies. PHILADELPHIA, Dec. 11, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) ("MoonLake" or the "Company") on behalf of investors who purchased MoonLake shares during the period of March 10, 2024 through September 29, 2025 (the "Class Period"). Investor Deadline: Investors who purchased ...